NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-132076

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedMycosis fungoides or Sezary syndrome
Date of first enrollment
Target sample size
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : S-6810 Dosage And administration of the intervention : Intravenous Control intervention name : null

Outcome(s)

Primary OutcomeSafety
Secondary OutcomeEfficacy (response rate)

Key inclusion & exclusion criteria

Age minimum20
Age maximum
GenderBOTH
Include criteriaMain inclusion criteria 1. Patients who completed the phase 2 open-label study.
Exclude criteriaMain exclusion criteria 1. Patients whose therapy evaluation in the phase 2 open-label study was progressive disease, or patients who got worse in obvious at end of administration. 2. Patients who withdrew from the phase 2 open-label study.

Related Information

Contact

public contact
Name Shionogi & Co., Ltd. Corporate Communications Department
Address http://www.shionogi.co.jp/information/inquiry_entrance.html
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation